|
|
||||||||
AJP - Endocrinology and Metabolism, Vol 264, Issue 4 E483-E489, Copyright © 1993 by American Physiological Society
ARTICLES |
E. R. Levin
Department of Medicine, University of California, Irvine 92717.
The natriuretic peptide family of proteins acts through two distinct classes of receptors that signal through entirely different mechanisms. The elucidation of the structure of the guanylate cyclase-containing receptor proteins has provided a better understanding of the mechanisms by which the natriuretic peptides regulate diverse functions of salt and water balance, in conjunction with other vasoactive peptides. A second receptor class was named for the originally described function of this protein to clear the natriuretic peptides from plasma. The mechanism of signaling for the natriuretic peptide clearance receptor is not firmly established. All known members of the natriuretic peptide family bind to, and can theoretically act through, the clearance receptor. This review summarizes the known features of the natriuretic peptide clearance receptor, a protein that contains extracellular and transmembrane domains and a short cytoplasmic segment. Recent studies have pointed to new and potentially important functions for this protein in mediating the actions of the natriuretic peptides.
This article has been cited by other articles:
![]() |
R. A. Rose and W. R. Giles Natriuretic peptide C receptor signalling in the heart and vasculature J. Physiol., January 15, 2008; 586(2): 353 - 366. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Schmitt, A. Qasem, C. McEniery, I. B. Wilkinson, V. Tatarinoff, K. Noble, J. Klemes, N. Payne, M. P. Frenneaux, J. Cockcroft, et al. Role of natriuretic peptides in regulation of conduit artery distensibility Am J Physiol Heart Circ Physiol, September 1, 2004; 287(3): H1167 - H1171. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. E. Woodard, X. Li, and J. A. Rosado Water deprivation enhances the inhibitory effect of natriuretic peptides on cAMP synthesis in rat renal glomeruli Am J Physiol Renal Physiol, September 1, 2004; 287(3): F418 - F426. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Rose, A. E. Lomax, and W. R. Giles Inhibition of L-type Ca2+ current by C-type natriuretic peptide in bullfrog atrial myocytes: an NPR-C-mediated effect Am J Physiol Heart Circ Physiol, December 1, 2003; 285(6): H2454 - H2462. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Baldini, P. De Vito, A. Martino, M. Fraziano, C. Grimaldi, P. Luly, F. Zalfa, and V. Colizzi Differential sensitivity of human monocytes and macrophages to ANP: a role of intracellular pH on reactive oxygen species production through the phospholipase involvement J. Leukoc. Biol., April 1, 2003; 73(4): 502 - 510. [Abstract] [Full Text] [PDF] |
||||
![]() |
A K Kiemer and A M Vollmar The atrial natriuretic peptide regulates the production of inflammatory mediators in macrophages Ann Rheum Dis, November 1, 2001; 60(90003): iii68 - 70. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. SENGENÈS, M. BERLAN, I. DE GLISEZINSKI, M. LAFONTAN, and J. GALITZKY Natriuretic peptides: a new lipolytic pathway in human adipocytes FASEB J, July 1, 2000; 14(10): 1345 - 1351. [Abstract] [Full Text] |
||||
![]() |
A. K. Kiemer, T. Hartung, and A. M. Vollmar cGMP-Mediated Inhibition of TNF-{alpha} Production by the Atrial Natriuretic Peptide in Murine Macrophages J. Immunol., July 1, 2000; 165(1): 175 - 181. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. G. MELO, M. E. STEINHELPER, S. C. PANG, Y. TSE, and U. ACKERMANN ANP in regulation of arterial pressure and fluid-electrolyte balance: lessons from genetic mouse models Physiol Genomics, June 29, 2000; 3(1): 45 - 58. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. d. l. A. Costa, L. V. G. Bosc, M. P. Majowicz, N. A. Vidal, A. M. Balaszczuk, and C. T. Arranz Atrial Natriuretic Peptide Modifies Arterial Blood Pressure Through Nitric Oxide Pathway in Rats Hypertension, May 1, 2000; 35(5): 1119 - 1123. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. R. Gower Jr., K. F. Salhab, W. L. Foulis, N. Pillai, J. R. Bundy, D. L. Vesely, P. J. Fabri, and J. R. Dietz Regulation of atrial natriuretic peptide gene expression in gastric antrum by fasting Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2000; 278(3): R770 - R780. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Takida, B. J. Elmquist, and G. J. Trachte C-Type Natriuretic Peptide Attenuates Evoked Dopamine Efflux by Influencing Go{alpha} Hypertension, January 1, 1999; 33(1): 124 - 129. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Galligan Focus on: "G protein-dependent activation of smooth muscle eNOS via natriuretic peptide clearance receptor" Am J Physiol Cell Physiol, December 1, 1998; 275(6): C1407 - C1408. [Full Text] [PDF] |
||||
![]() |
A. K. Kiemer and A. M. Vollmar Autocrine Regulation of Inducible Nitric-oxide Synthase in Macrophages by Atrial Natriuretic Peptide J. Biol. Chem., May 29, 1998; 273(22): 13444 - 13451. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Frajewicki, L. Kahana, H. Yechieli, V. Brod, R. Kohan, and H. Bitterman Effects of severe hemorrhage on plasma ANP and glomerular ANP receptors Am J Physiol Regulatory Integrative Comp Physiol, November 1, 1997; 273(5): R1623 - R1630. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Pham, S. Sediame, G. Maistre, F. Roudot-Thoraval, P.-E. Chabrier, A. Carayon, and S. Adnot Renal and vascular effects of C-type and atrial natriuretic peptides in humans Am J Physiol Regulatory Integrative Comp Physiol, October 1, 1997; 273(4): R1457 - R1464. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Nagase, K. Ando, T. Katafuchi, A. Kato, S. Hirose, and T. Fujita Role of Natriuretic Peptide Receptor Type C in Dahl Salt-Sensitive Hypertensive Rats Hypertension, August 1, 1997; 30(2): 177 - 183. [Abstract] [Full Text] |
||||
![]() |
A. Pedram, M. Razandi, R.-M. Hu, and E. R. Levin Vasoactive Peptides Modulate Vascular Endothelial Cell Growth Factor Production and Endothelial Cell Proliferation and Invasion J. Biol. Chem., July 4, 1997; 272(27): 17097 - 17103. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. C. Davidson, C. S. Barr, and A. D. Struthers C-Type Natriuretic Peptide : An Endogenous Inhibitor of Vascular Angiotensin-Converting Enzyme Activity Circulation, March 15, 1996; 93(6): 1155 - 1159. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |